Director/PDMR Shareholding

RNS Number : 1464I
Oxford Nanopore Technologies plc
12 April 2022
 

12 April 2022

Oxford Nanopore Technologies plc (the "Company")

Director/PDMR Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified that, on 12 April 2022, Adrian Hennah, a Non-executive Director of the Company, purchased a total of 14,125 ordinary shares at a price of 355.705p per share.

Name

Number of shares acquired

Price per share (pence)

Adrian Hennah

14,125

355.705p

 

This announcement is made pursuant to the Company's obligations under Article 19 of the UK Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adrian Hennah

2

Reason for the notification

a)

Position/status

Non-executive Director

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies PLC

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Purchase of shares in the Company

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

355.705p

14,125

d)

Aggregated information

- Aggregated volume

 - Aggregated price



14,125 shares

£50,243.33

e)

Date of the transaction

12 April 2022

f)

Place of the transaction

London Stock Exchange (XLON)

[ENDS]

Enquiries:

Investors

ir@nanoporetech.com  

Media  

media@nanoporetech.com

oxfordnanoporetechnologies@tulchangroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBGDSSXBDGDD
UK 100

Latest directors dealings